The health utility of Graves' disease treatments at Damnoensaduak hospital

Valeerat Vongkasem, Surasit Lochid-amnuay


The objectives of this cross-sectional study were to compare the utility of anti-thyroid drug and radioactive iodine in patients  with Graves' disease (GD) at Damnoensaduak hospital, Ratchaburi, Thailand. This study included all patients who were diagnosed with Graves' disease during September 1, 2011 to January 31, 2012. There were 114 patients with Graves' disease in whom 80 patients were treated with anti-thyroid drug and 34 patients were treated with radioactive iodine. The utility was measured by using the EuroQol (EQ-5D) in Thai version. The health utility of  patients treated with anti-thyroid drug or radioactive iodine were compared by using t-test independent. The results showed that the utility of GD was 0.698 ± 0.22. The utility of anti-thyroid drug and radioactive iodine patient were 0.675 ± 0.23 and 0.754 ± 0.18 respectively. The utility of anti-thyroid drug was not significant different from the utility of radioactive iodine (p-value=0.07).


Graves' disease, Health utility, Anti-thyroid drug, Radioactive iodine

Full Text: PDF